Tickers

1. Composite Trajectory Verdict

For a commercial bank like SYBT, the income statement and balance sheet carry roughly equal weight because profitability drivers (net interest margin, credit costs) and balance sheet strength (asset quality, capital ratios) are both critical to assessing financial performance.

Composite Trajectory: Improving

Earnings and balance sheet trends are both improving: net income rose 22% year-over-year to $140.2 million, net interest margin expanded 22 basis points to 3.53%, and the efficiency ratio improved to 53.41% from 56.20% (10-K 2025, MD&A Overview – Operating Results (FTE); 10-K 2025, MD&A Net Interest Income - Overview; 10-K 2025, MD&A Non-GAAP Financial Measures). On the balance sheet, total loans grew 8% to $7.04 billion, total deposits rose 9%, tangible common equity ratio increased to 9.32% from 8.44%, and non-performing assets fell to $13.2 million from $22.2 million (10-K 2025, MD&A Financial Condition – December 31, 2025 Compared to December 31, 2024; 10-K 2025, MD&A Non-GAAP Financial Measures; 10-K 2025, MD&A Non-performing Loans and Assets). Cash flow data is insufficient to assess, but no deterioration is evident in the two available statements.

2. Red Flags

• Non-interest income growth slowed to 2% in 2025 (from 3% in 2024), with wealth management & trust revenue flat (-$35 thousand) and debit/credit card income declining 1% (10-K 2025, MD&A Non-Interest Income table).
• Deposit mix shifted toward higher-cost time deposits: non-interest bearing deposits fell $20 million (1%) while time deposits surged $499 million (40%) (10-K 2025, MD&A Deposits).
• Management explicitly warns that non-interest income growth will be challenged in 2026 and that asset quality metrics, currently at historically strong levels, are likely to normalize (10-K 2025, MD&A Potential Challenges for 2026).
• The company is actively managing the balance sheet to remain under the $10 billion total asset regulatory threshold, which may constrain future growth (10-K 2025, MD&A Potential Challenges for 2026).
• Uninsured deposits remain high at an estimated $3.3 billion (approximately 42% of total deposits) despite the new ICS product (10-K 2025, MD&A Deposits).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Improving

Net income available to stockholders increased 22% to $140.2 million in 2025 from $114.5 million in 2024, following a 6% increase in 2024 (10-K 2025, MD&A Overview – Operating Results (FTE)). Net interest income (FTE) grew 17% to $300.7 million, driven by a 12% rise in average loans and a 19 basis point increase in earning asset yield to 5.50% (10-K 2025, MD&A Net Interest Income - Overview). Net interest margin (FTE) expanded 22 basis points to 3.53% as the cost of interest-bearing liabilities declined 12 basis points to 2.61% (10-K 2025, MD&A Net Interest Income - Overview). Non-interest income rose modestly (2%) to $96.9 million, while non-interest expenses increased 7% to $212.4 million, resulting in an improved efficiency ratio (FTE) of 53.41% versus 56.20% (10-K 2025, MD&A Non-Interest Income table; 10-K 2025, MD&A Non-interest Expenses table; 10-K 2025, MD&A Non-GAAP Financial Measures). Provision for credit losses fell to $5.6 million from $8.8 million, and net charge-offs remained minimal at $626 thousand (10-K 2025, MD&A Provision for Credit Losses).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Insufficient Data

The provided filings do not include a statement of cash flows or sufficient cash flow data to compute operating, investing, or financing cash flow trends. The 10-K MD&A includes only a qualitative "Sources and Uses of Cash" section without numerical cash flow figures (10-K 2025, MD&A Sources and Uses of Cash). Quarterly 10-Q filings, which would contain interim cash flow statements, are listed but their contents are not provided in the document set.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Improving

Total assets grew 8% to $9.54 billion at December 31, 2025 from $8.86 billion a year earlier (10-K 2025, MD&A Financial Condition – December 31, 2025 Compared to December 31, 2024). Total loans increased 8% to $7.04 billion, with growth across CRE, C&D, C&I, and residential real estate segments (10-K 2025, MD&A Loans). Total deposits rose 9% ($625 million), driven by a 40% surge in time deposits, though non-interest bearing deposits declined 1% (10-K 2025, MD&A Deposits). Stockholders' equity increased 14% to $1.08 billion, lifting the tangible common equity ratio to 9.32% from 8.44% (10-K 2025, MD&A Non-GAAP Financial Measures). Asset quality improved: non-performing assets dropped to $13.2 million (0.14% of total assets) from $22.2 million (0.25%), and the ACL coverage of non-performing loans rose to 705% from 391% (10-K 2025, MD&A Non-performing Loans and Assets). The allowance for credit losses to total loans ratio edged down to 1.30% from 1.33% (10-K 2025, MD&A Allowance for Credit Losses on Loans).

6. Data Gaps

• Quarterly cash flow statements (operating, investing, financing) for all periods – would require the 10-Q filings for Q1–Q3 2025 and Q1–Q2 2026.
• Detailed quarterly income statement and balance sheet line items to compute intra-year trends – would require the same 10-Q filings.
• Year-over-year quarterly comparisons for net interest income, provision expense, and non-interest revenue – would require the 10-Q filings.
• Cash flow from operations versus net income to assess earnings quality – would require the 10-K consolidated statements of cash flows (not included in the provided excerpt) and quarterly 10-Q cash flow statements.